Global Breast-Conserving Surgery Market Growth (Status and Outlook) 2023-2029

Global Breast-Conserving Surgery Market Growth (Status and Outlook) 2023-2029

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.
LPI (LP Information)' newest research report, the “Breast-Conserving Surgery Industry Forecast” looks at past sales and reviews total world Breast-Conserving Surgery sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast-Conserving Surgery sales for 2023 through 2029. With Breast-Conserving Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast-Conserving Surgery industry.
This Insight Report provides a comprehensive analysis of the global Breast-Conserving Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast-Conserving Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast-Conserving Surgery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast-Conserving Surgery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast-Conserving Surgery.
The global Breast-Conserving Surgery market size is projected to grow from US$ 1499.7 million in 2022 to US$ 2481.4 million in 2029; it is expected to grow at a CAGR of 7.5% from 2023 to 2029.
Global key players of breast-conserving surgery include Hologic, BD, Danaher, Carl Zeiss Meditech, Merit Medical, etc. The top five players hold a share about 42%. Service providers are mainly located in North America and Europe, they occupied for a share over 47%. The largest market is North America, holds a share about 43%, followed by Europe and Asia-Pacific, with around 26% and 25% market share respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of Breast-Conserving Surgery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Lumpectomy Systems
Lumpectomy Surgical Tools
Segmentation by application
Hospitals
Ambulatory Surgical Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hologic
BD
Danaher
Carl Zeiss Meditech
Merit Medical
Argon Medical Devices
IceCure
Endomagnetics
SOMATEX Medical
Ranfac
STERYLAB
SamanTree Medical
Perimeter Medical Imaging AI
Dilon Technologies
XEOS Medical

Please note: The report will take approximately 2 business days to prepare and deliver.